Research article Special Issues

PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma


  • Received: 30 July 2021 Accepted: 27 September 2021 Published: 09 November 2021
  • Plasmacytoma variant translocation 1 (PVT1) is involved in multiple signaling pathways and plays an important regulatory role in a variety of malignant tumors. However, its role in the prognosis and immune invasion of bladder urothelial carcinoma (BLCA) remains unclear. This study investigated the expression of PVT1 in tumor tissue and its relationship with immune invasion, and determined its prognostic role in patients with BLCA. Patients were identified from the cancer genome atlas (TCGA). The enrichment pathway and function of PVT1 were explained by gene ontology (GO) term analysis, gene set enrichment analysis (GSEA) and single-sample gene set enrichment analysis (ssGSEA), and the degree of immune cell infiltration was quantified. Kaplan–Meier analysis and Cox regression were used to analyze the correlation between PVT1 and survival rate. PVT1-high BLCA patients had a lower 10-year disease-specific survival (DSS P < 0.05) and overall survival (OS P < 0.05). Multivariate Cox regression analysis showed that PVT1 (high vs. low) (P = 0.004) was an independent prognostic factor. A nomogram was used to predict the effect of PVT1 on the prognosis. PVT1 plays an important role in the progression and prognosis of BLCA and can be used as a medium biomarker to predict survival after cystectomy.

    Citation: Peiyuan Li, Gangjie Qiao, Jian Lu, Wenbin Ji, Chao Gao, Feng Qi. PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma[J]. Mathematical Biosciences and Engineering, 2022, 19(1): 169-190. doi: 10.3934/mbe.2022009

    Related Papers:

    [1] Oluwafolajimi Adesanya, Tolulope Oduselu, Oluwawapelumi Akin-Ajani, Olubusuyi M. Adewumi, Olusegun G. Ademowo . An exegesis of bacteriophage therapy: An emerging player in the fight against anti-microbial resistance. AIMS Microbiology, 2020, 6(3): 204-230. doi: 10.3934/microbiol.2020014
    [2] Ashrafus Safa, Jinath Sultana Jime, Farishta Shahel . Cholera toxin phage: structural and functional diversity between Vibrio cholerae biotypes. AIMS Microbiology, 2020, 6(2): 144-151. doi: 10.3934/microbiol.2020009
    [3] Abdullahi Yusuf Muhammad, Malik Amonov, Chandrika Murugaiah, Atif Amin Baig, Marina Yusoff . Intestinal colonization against Vibrio cholerae: host and microbial resistance mechanisms. AIMS Microbiology, 2023, 9(2): 346-374. doi: 10.3934/microbiol.2023019
    [4] Rochelle Keet, Diane Rip . Listeria monocytogenes isolates from Western Cape, South Africa exhibit resistance to multiple antibiotics and contradicts certain global resistance patterns. AIMS Microbiology, 2021, 7(1): 40-58. doi: 10.3934/microbiol.2021004
    [5] Ogueri Nwaiwu, Chiugo Claret Aduba . An in silico analysis of acquired antimicrobial resistance genes in Aeromonas plasmids. AIMS Microbiology, 2020, 6(1): 75-91. doi: 10.3934/microbiol.2020005
    [6] Chioma Lilian Ozoaduche, Katalin Posta, Balázs Libisch, Ferenc Olasz . Acquired antibiotic resistance of Pseudomonas spp., Escherichia coli and Acinetobacter spp. in the Western Balkans and Hungary with a One Health outlook. AIMS Microbiology, 2025, 11(2): 436-461. doi: 10.3934/microbiol.2025020
    [7] Philip Serwer . Restoring logic and data to phage-cures for infectious disease. AIMS Microbiology, 2017, 3(4): 706-712. doi: 10.3934/microbiol.2017.4.706
    [8] Rosette Mansour, Mohammad H. El-Dakdouki, Sara Mina . Phylogenetic group distribution and antibiotic resistance of Escherichia coli isolates in aquatic environments of a highly populated area. AIMS Microbiology, 2024, 10(2): 340-362. doi: 10.3934/microbiol.2024018
    [9] Neda Askari, Hassan Momtaz, Elahe Tajbakhsh . Acinetobacter baumannii in sheep, goat, and camel raw meat: virulence and antibiotic resistance pattern. AIMS Microbiology, 2019, 5(3): 272-284. doi: 10.3934/microbiol.2019.3.272
    [10] Mohammad Abu-Sini, Mohammad A. Al-Kafaween, Rania M. Al-Groom, Abu Bakar Mohd Hilmi . Comparative in vitro activity of various antibiotic against planktonic and biofilm and the gene expression profile in Pseudomonas aeruginosa. AIMS Microbiology, 2023, 9(2): 313-331. doi: 10.3934/microbiol.2023017
  • Plasmacytoma variant translocation 1 (PVT1) is involved in multiple signaling pathways and plays an important regulatory role in a variety of malignant tumors. However, its role in the prognosis and immune invasion of bladder urothelial carcinoma (BLCA) remains unclear. This study investigated the expression of PVT1 in tumor tissue and its relationship with immune invasion, and determined its prognostic role in patients with BLCA. Patients were identified from the cancer genome atlas (TCGA). The enrichment pathway and function of PVT1 were explained by gene ontology (GO) term analysis, gene set enrichment analysis (GSEA) and single-sample gene set enrichment analysis (ssGSEA), and the degree of immune cell infiltration was quantified. Kaplan–Meier analysis and Cox regression were used to analyze the correlation between PVT1 and survival rate. PVT1-high BLCA patients had a lower 10-year disease-specific survival (DSS P < 0.05) and overall survival (OS P < 0.05). Multivariate Cox regression analysis showed that PVT1 (high vs. low) (P = 0.004) was an independent prognostic factor. A nomogram was used to predict the effect of PVT1 on the prognosis. PVT1 plays an important role in the progression and prognosis of BLCA and can be used as a medium biomarker to predict survival after cystectomy.



    V. cholera is a gram-negative, facultative, motile anaerobe that secrets a diarrhoeagenic protein called cholera toxin [1]. The organism has over 200 serogroups, but only the O1 and O139 serogroups have been linked to the diarrheal disease commonly known as cholera [2]. In third world countries, the organism typically transmits by drinking contaminated surface water [3], whereas, in developed countries, transmissions are associated with raw or undercooked shellfish consumption [4]. Cholera is a frequent occurrence in Bangladesh, with seasonal outbreaks occurring annually [5]. Since V. cholera is predominantly an aquatic organism, the propagation and epidemiology of these outbreaks are highly influenced by contaminated water sources and flooding. In most rural areas of Bangladesh, access to potable clean drinking water is minimal, especially during annual flooding. A vast majority of the population still drinks untreated surface water in rural areas of the country and most of these annual outbreak buds in those populations.

    Furthermore, underground water sources like tube wells are often submerged and contaminated by flood water during annual flooding. Thus, it is crucial to perform a comparative study of V. cholera contamination among different surface and underground water sources as a part of consistent surveillance operation. Besides, annual cholera outbreaks are often treated with the same group of antibiotics, resulting in a high antibiotic resistance in V. cholera strains against commonly used antibiotics. A yearly evaluation of the antibiotic resistance profile of field strains is necessary for the effective therapeutic use of available antibiotics. Therefore, this research aimed at quantifying V. spp. in different water sources of Bangladesh and evaluating the antibiotic resistance profile of V. cholera to estimate and mitigate the risk of the annual cholera outbreak.

    A total of 45 environmental water samples were aseptically collected from pond, river and tube-well of different designated areas of Gazipur district, Bangladesh (Benupur, Chandabaha, Kaliakoir, Sutrapur and Begunbari). Following collection 4 samples are then serially diluted in alkaline peptone water and streak on selective media of Thiosulfate Citrate Bile Salts Sucrose (TCBS) agar, (Hi media, India) and incubated 37 °C for 24 hours. Following incubation, colonies with shiny yellow color and smooth, convex, and slightly flattened texture with opaque centers (Figure 1A, 1B) were used in viable count of V. spp. [6]. For bacteria isolation 1 mL of buffer peptone solution (1:10 dilution) was enriched in nutrient broth at 37 °C for 16 hours and then transferred in selective media (TCBS agar plate) for incubation (37 °C for 24 hours). Then one colony was randomly selected from each plate for biochemical analysis and hemolysis test (Figure 1C, 1D).

    Table 1.  Concentration (µg /disc) of antibiotic disc used for antimicrobial resistance test.
    Antibiotics Symbol Disc concentration (µg /disc)
    Ciprofloxacin (CIP) 5
    Gentamycin (GEN) 10
    Penicillin (P) 10
    Vancomycin (VA) 30
    Cephalexin (CN) 30
    Chloramphenicol (C) 30
    Tetracycline (TE) 30
    Erythromycin (E) 15
    Sulfamethoxazole (SXT) 25
    Nalidixic Acid (NA) 30
    Azithromycin (AZ) 15

     | Show Table
    DownLoad: CSV

    V. spp. isolated in selective media were confirmed as V. cholera by different biochemical tests Catalase, Oxidase, MR, VP, Indole, glucose, maltose, mannitol and sucrose fermentation) according to the methodology described in [7].

    Table 2.  Bacterial concentration in different sources collected from 5 different locations.
    Sample type Bacterial conc. (Log CFU/mL)
    10−3 DF1 10−4 DF1 10−5 DF1
    River 4.96A 5.89A 6.79a
    Pond 4.98A 5.92A 6.80a
    Tube well 4.86B 5.73B 6.06b
    SEM2 0.028 0.035 0.500
    P value <0.0001 <0.0001 <0.0001

     | Show Table
    DownLoad: CSV

    Antibiotic sensitivity test was performed according to Kriby-Bauer disc diffusion method [9] and following the guideline of Clinical and Laboratory Standards Institute [8]. A total of 11 commercially available antibiotics were used (Table 1) in this research to assess drug susceptibility and resistance of isolated species (Mast diagnostics Mersey side, UK). A single colony of pure culture isolated from the samples was incubated in nutrient broth at 37 °C for 16 hours. Then 0.1 ml of broth was spread on Mueller-Hinton agar plate using a cell spreader and an antibiotic disc was placed on top. The plates were then incubated in 37 °C for 24 hours. After incubation, the zone of inhibition near the discs was measured using a millimeter scale and categorized as resistant or sensitive according to the manufacturer's recommendation (Table 1).

    Table 3.  V. spp. concentration in water samples of 5 different location (Benupur, Chandabadha, Kaliakoir, Sutrapur and Begunbari).
    Sample type DF1 Bacterial concentration in each location (Log CFU/mL)
    Benupur Chandabaha Kaliakoir Sutrapur Begunbari
    River Burigonga 10−3 4.95 5.00 4.93 4.99 4.94
    10−4 5.88 5.93 5.87 5.90 5.88
    10−5 6.79 6.80 6.81 6.81 6.79
    Pond 10−3 4.94 4.99 5.00 4.99 5.00
    10−4 5.90 5.89 5.93 5.90 5.87
    10−5 6.80 6.79 6.80 6.77 6.72
    Tube-well 10−3 4.91 4.86 4.86 4.83 5.00
    10−4 5.81 5.76 5.71 5.68 5.89
    10−5 6.62 6.52 6.46 6.57 7.00

    Average 5.84 5.83 5.82 5.83 5.90
    SEM2 0.261 0.257 0.261 0.259 0.247

    P-value 0.996

    *Note: CFU= colony forming unite, 1DF = Dilution factor, 2SEM= Standard error of mean

     | Show Table
    DownLoad: CSV

    A total of 5 replicate samples were randomly collected from each of the 5 different locations (Benupur, Chandabaha, Kaliakoir, Sutrapur, Begunbari) of each 3 water sources (river, pond and tube-well). Bacterial concentration in samples were log transformed and subjected to Shapiro-Wilk test for normality analysis. Bartlett's Test was performed to ensure the homogeneity of variance among the collected samples. The bacterial concentration in different water sources and at different locations were analyzed with one-way ANOVA using the GLM procedure of SAS software (version 9.2) under the following model. Yij = µ + Ti + δL + ϵij. Where, Yij = Bacterial concentration in each sample; µ = Overall mean bacterial concentration; Ti = Effect of water source; δL = Blocking effect of location and ϵij = random error. We assumed that the variation within the model, caused by from sampling location are normally distributed with a mean of 0 and a variance of σL2. Random error ϵij of the model is also normally distributed with a mean of 0 and a variance of σ2. Both variances σL2 and σ2 are independent of each other. For data analysis, P < 0.05 was considered statistically significant and when a significant difference is detected, the were subjected to the least significant difference test (LSD) for mean separation.

    Figure 1.  V. spp. on Nutrient's Agar (A), TCBS Agar left the yellow colony and green colony right (B), blood agar hemolytic colony (C), and non-hemolytic colony on blood agar (D).
    Figure 2.  Biochemical test results. Indole test (A), Methyl red test (B), Voges-Proskauer test (C), Simmons citrate test (D), KIA test (E), and MIU test (F).
    Table 4.  Biochemical tests result of 12 isolated strains of V. cholera.
    Tests Results
    R1 R3 R5 R6 R7 P1 P3 P5 P6 T3 T4 T7
    Nit + + + + + + + + + + + +
    Ox + + + + + + - + + + - +
    Ind + + + + - + + + + + + +
    Ci + + + + + + + + + + + +
    MR - - - + - - - + - - - -
    VP + + + + + + + + + + + +
    MIU + + + + + + + - + + + +
    Urease - - - - - - + - - - - -
    KIA Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= - Yb, Ys, G= -H2S= -
    Glucose + + + - + + - + + + - +
    Maltose + + + + + + + + + - + +
    Mannitol + + + + + + + + + + + +
    Sucrose + + + + - + + + + + + +
    Gelatin hydrolysis + + + + + + - + + + + +

    *Note: Legends: SL No.: Serial Number, Nit: Nitrate utilization test, Ox: Oxidase test, In: Indole test, Ci: Citrate test, MR: Methyl Red test, VP: Voges-Proskauer test, MIU: Motility indole urease, KIA: Kinglar iron agar +: positive, -: Negative, Y: Yellow, B: Butt, S: Slant, G: Gas.

     | Show Table
    DownLoad: CSV

    Viable counts were performed on TCBS agar plate which selects V. spp. based on their sucrose fermentation characteristics and the result is presented in Table 2. There was significantly higher V. spp. in pond and river water than tube-well water (P < 0.001) at all 3 dilution levels (dilution factor: 103, 104 and 105). Bacterial concentration did not vary significantly based on the location of sample collection (P > 0.05) (Table 3).

    Table 5.  Comparative prevalence of V. cholera among the V. spp. isolated from different water sources.
    Bacterial isolate River water Pond water Tube well water Total isolates Percentage (%)
    V. cholera 5 (41.67%) 4 (40%) 3(37.5%) 12 40
    V. parahimulyticus 7 (58.33%) 6 (60%) 5 (62.5%) 18 60
    Total isolates 12 10 8 30

     | Show Table
    DownLoad: CSV

    Total of 14 biochemical tests were performed on isolates of different samples and the result of those tests are presented in Table 4. Out of the 30 isolates, 12 isolates were positive in nitrate, oxidase, indole, citrate utilization, MR, motility, glucose, sucrose, mannitol, maltose, and gelatin hydrolysis agar test (Figure 2A, 2F). V. spp. were also found to be negative in MR, urease, and kingler iron agar test. Hemolytic characteristics of the isolates were also evaluated to differentiate between V. cholera and V. parahaemolyticus (Figure 1C, 1D). V. cholera are known to cause β-hemolysis whereas V. parahaemolyticus causes α-hemolysis. Based on this characteristic 12 of the initial isolates were classified as V. cholera and remaining 18 was classified as V. parahaemolyticus.

    The comparative prevalence of V. cholera among the V. spp. isolated from different water sources are presented in Table 5. River water had the highest prevalence of V. cholera (5 out of 12 isolates; 41.67%) whereas, tube-well water had the lowest prevalence (3 out of 8; 37.5%).

    Table 6.  Outcome of antibiotic sensitivity test of 12 V. cholera isolates obtained from different water samples.
    Isolate GEN CIP CN VA P C TE E NA AZ SXT
    R1 S S S R R S S I I S S
    R3 S S S R R S S R R S S
    R5 S S S I R S I R R S S
    R6 S S S R R S I I R R S
    R7 S S S R R R R R R S S
    P1 S S S R R S R R R S S
    P3 S S S R R S R R R S M
    P5 S S S R R I I R R S S
    P6 S S I I I S I R R R S
    T3 S S I R R S S I R S S
    T4 S S R R R S S I R S S
    T7 S S R I R S I R R S S

    *Note: GEN: Gentamycin, CIP: Ciprofloxacin, CN: Cephalexin, VA: Vancomycin, P: Penicillin, C: Chloramphenicol, TE: Tetracycline, E: Erythromycin, NA: Nalidixic Acid, AZ: Azithromycin, SXT: Sulfamethoxazole, R: River, P; Pond; T; Tap, s: Sensitive and r: Resistance. R1, R3, R5, R6, R7 are the V. cholera isolates collected from rivers, P1, P3, P5 and P6 are the V. cholera isolates collected from pond, T3, T4 and T7 are the V. cholera isolates collected from tube-well.

     | Show Table
    DownLoad: CSV

    The results of antibiotic sensitivity test performed on 12 V. cholera isolates are presented in Table 6. The antibiotic sensitivity profiles of those isolates have been compiled in Table 7. All 12 isolates showed 100% sensitivity toward Gentamicin and ciprofloxacin. All the isolates showed multidrug resistance (Table 6). However, these isolates were susceptible to Chloramphenicol (91.67%), and Sulfamethoxazole (91.67%). Azithromycin (66.67%). Tetracycline (33.33%), and Cephalexin (16.67%) had moderate to low sensitivity. All 12 isolates showed 100% resistance toward Penicillin, Vancomycin, Erythromycin, and Nalidixic Acid. This result is congruent with the study of [10] performed in neighboring country Nepal, where they found their isolates sensitive to Ciprofloxacin, Ampicillin, and resistant to Nalidixic acid. However, unlike this study, their isolates also showed higher sensitivity toward Erythromycin and Tetracycline. The majority of resistance in environmental species are thought to have originated from historically resistant organisms. As a result, it's essential to keep track of both the frequency and the antimicrobial resistance profile of V. cholera to identify the high-risk water sources. To minimize the risk of cholera transmission through contaminated water, we recommend screening various water sources against this pathogenic bacteria before using it for washing, drinking and irrigation. Vulnerable populations, especially farmers in rural areas, should take appropriate precautions to avoid cholera transmission through water [11]. There were some limitations to our research. Due to the funding constrain, a limited number of samples were collected, which might not be sufficient to draw a precise conclusion. Our analysis still lacks molecular characterization of the isolates, which might have strengthened our conclusion.

    Table 7.  Antibiotic sensitivity profile of 12 isolates V. spp. obtained from different water samples.
    Organism Antibiotics Susceptibility (%) Resistance (%)
    V. cholera Gentamycin (GEN) 12(100%) 0(0%)
    Ciprofloxacin (CIP) 12(100%) 0(0%)
    Cephalexin (CN) 2(16.67%) 10(83.33%)
    Vancomycin (VA) 0(0%) 12(100%)
    Penicillin (P) 0(0%) 12(100%)
    Chloramphenicol (C) 11(91.67%) 1(8.33%)
    Tetracycline (TE) 4(33.33%) 8(66.67%)
    Erythromycin (E) 0(0%) 12(100%)
    Sulfamethoxazole (SXT) 11(91.67%) 1(8.33%)
    Nalidixic Acid (NA) 0(0%) 12(100%)
    Azithromycin (AZ) 8(66.67%) 4(33.33%)

     | Show Table
    DownLoad: CSV

    Based on the data of our experiment we conclude that V. cholera is endemic to the surface water sources like pond and river in Gazipur region of Bangladesh. Underground water like tube well has comparatively lower concentration of V. cholera Antibiotics like, Gentamicin, Ciprofloxacin, Chloramphenicol, Sulfamethoxazole and Azithromycin are highly effective against the V. cholera isolates collected in this study. We suggest the application of these antibiotics in therapeutics of annual cholera outbreak. Furthermore, we highly recommend prioritizing underground water over surface water as drinking water source.



    [1] L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal, Global cancer statistics, 2012, CA Cancer J. Clin., 65 (2015), 87-108. doi: 10.3322/caac.21262.
    [2] W. J. Kim, S. C. Bae, Molecular biomarkers in urothelial bladder cancer, Cancer Sci., 99 (2008), 646-652. doi: 10.1111/j.1349-7006.2008.00735.x. doi: 10.1111/j.1349-7006.2008.00735.x
    [3] R. L. Siegel, K. D. Miller, A. Jemal, Cancer statistics, 2016, CA Cancer J. Clin., 66 (2016), 7-30. doi: 10.3322/caac.21332.
    [4] D. Tolomeo, A. Agostini, G. Visci, D. Traversa, C. T. Storlazzi, PVT1: A long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts, Gene, 779 (2021), 145497. doi: 10.1016/j.gene.2021.145497.
    [5] Y. Y. Tseng, B. S. Moriarity, W. Gong, R. Akiyama, A. Tiwari, H. Kawakami, et al., PVT1 dependence in cancer with MYC copy-number increase, Nature, 512 (2014), 82-86. doi: 10.1038/nature13311.
    [6] Y. Kikuchi, S. Tokita, T. Hirama, V. Kochin, M. Nakatsugawa, T. Shinkawa, et al., CD8+ T-cell immune surveillance against a tumor antigen encoded by the oncogenic long non-coding RNA, PVT1, Cancer Immunol. Res., 9 (2021), 1342-1353. doi: 10.1158/2326-6066.CIR-20-0964.
    [7] E. Tesfaye, E. Martinez-Terroba, J. Bendor, L. Winkler, C. Olivero, K. Chen, et al., The p53 transcriptional response across tumor types reveals core and senescence-specific signatures modulated by long noncoding RNAs, Proc. Natl. Acad. Sci. USA, 118 (2021). doi: 10.1073/pnas.2025539118.
    [8] K. Shigeyasu, S. Toden, T. Ozawa, T. Matsuyama, T. Nagasaka, T. Ishikawa, et al., The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer, Mol. Cancer, 19 (2020), 155. doi: 10.1186/s12943-020-01277-4.
    [9] Z. Liu, H. Zhang, LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma, Mol. Cancer, 8 (2017), 64273-64282. doi: 10.18632/oncotarget.19604. doi: 10.18632/oncotarget.19604
    [10] Y. Wang, J. Zhou, Z. Wang, P. Wang, S. Li, Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion, Biochem. Bioph. Res. Commun., 493 (2017), 429-436. doi: 10.1016/j.bbrc.2017.09.005. doi: 10.1016/j.bbrc.2017.09.005
    [11] M. Iden, S. Fye, K. Li, T. Chowdhury, R. Ramchandran, J. S. Rader, The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis, PLoS One, 11 (2016), e0156274. doi: 10.1371/journal.pone.0156274.
    [12] X. Yu, J. Zhao, Y. He, Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis, J BUON, 23 (2018), 48-54.
    [13] Y. R. Yang, S. Z. Zang, C. L. Zhong, Y. X. Li, S. S. Zhao, X. J. Feng, Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer, Int. J. Clin. Exp. Pathol, 7 (2014), 6929-6935.
    [14] Y. Wu, W. Gu, X. Han, Z. Jin, LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-beta pathway via miR-148a-3p/AGO1 axis, J. Cell Mol. Med., (2021). doi: 10.1111/jcmm.16700.
    [15] J. Yang, C. Li, A. Mudd, X. Gu, LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer, Biosci. Biotech. Bioch., 81 (2017), 2301-2306. doi: 10.1080/09168451.2017.1387048. doi: 10.1080/09168451.2017.1387048
    [16] M. Izadifard, H. Pashaiefar, M. Yaghmaie, M. Montazeri, M. Sadraie, M. Momeny, et al., Expression analysis of PVT1, CCDC26, and CCAT1 long noncoding RNAs in acute myeloid leukemia patients, Genet. Test. Mol. Bioma., 22 (2018), 593-598. doi: 10.1089/gtmb.2018.0143.
    [17] A. Abbate, D. Tolomeo, I. Cifola, M. Severgnini, A. Turchiano, B. Augello, et al., MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences, Leukemia, 32 (2018), 2152-2166. doi: 10.1038/s41375-018-0033-0.
    [18] N. Yazdi, M. Houshmand, A. Atashi, A. Kazemi, A. A. Najmedini, M. N. Zarif, Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia, Turk. J. Biol., 42 (2018), 405-413. doi: 10.3906/biy-1801-46. doi: 10.3906/biy-1801-46
    [19] H. Handa, K. Honma, T. Oda, N. Kobayashi, Y. Kuroda, K. Kimura-Masuda, et al., Long Noncoding RNA PVT1 Is Regulated by Bromodomain Protein BRD4 in Multiple Myeloma and Is Associated with Disease Progression, Int. J. Mol. Sci., 21 (2020). doi: 10.3390/ijms21197121.
    [20] A. C. Panda, I. Grammatikakis, K. M. Kim, S. De, J. L. Martindale, R. Munk, et al., Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1, Nucleic Acids Res., 45 (2017), 4021-4035. doi: 10.1093/nar/gkw1201.
    [21] L. Wan, M. Sun, G. J. Liu, C. C. Wei, E. B. Zhang, R. Kong, et al., Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating lats2 expression, Mol. Cancer Ther., 15 (2016), 1082-1094. doi: 10.1158/1535-7163.MCT-15-0707.
    [22] C. Zeng, X. Yu, J. Lai, L. Yang, S. Chen, Y. Li, Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia, J. Hematol. Oncol., 8 (2015), 126. doi: 10.1186/s13045-015-0223-4.
    [23] D. Guo, Y. Wang, K. Ren, X. Han, Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression, Exp. Cell Res., 362 (2018), 172-179. doi: 10.1016/j.yexcr.2017.11.014. doi: 10.1016/j.yexcr.2017.11.014
    [24] G. Ping, W. Xiong, L. Zhang, Y. Li, Y. Zhang, Y. Zhao, Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer, Am. J. Transl. Res., 10 (2018), 138-149.
    [25] X. Z. Wu, H. P. Cui, H. J. Lv, L. Feng, Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p, Biomed. Pharmacother., 112 (2019), 108627. doi: 10.1016/j.biopha.2019.108627.
    [26] Y. Cai, J. Wan, Competing endogenous RNA regulations in neurodegenerative disorders: current challenges and emerging insights, Front. Mol. Neurosci., 11 (2018), 370. doi: 10.3389/fnmol.2018.00370.
    [27] X. Qi, D. H. Zhang, N. Wu, J. H. Xiao, X. Wang, W. Ma, ceRNA in cancer: possible functions and clinical implications, J. Med. Genet., 52 (2015), 710-718. doi: 10.1136/jmedgenet-2015-103334. doi: 10.1136/jmedgenet-2015-103334
    [28] M. Chen, R. Zhang, L. Lu, J. Du, C. Chen, K. Ding, et al., LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA, Aging (Albany NY), 12 (2020), 22291-22312. doi: 10.18632/aging.202203.
    [29] C. Yu, L. Liu, W. Long, Z. Feng, J. Chen, L. Chao, et al., LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells, J. Cell Physiol., 234 (2019), 1346-1353. doi: 10.1002/jcp.26929.
    [30] V. Karantza, Keratins in health and cancer: more than mere epithelial cell markers, Oncogene, 30 (2011), 127-138. doi: 10.1038/onc.2010.456. doi: 10.1038/onc.2010.456
    [31] P. A. Coulombe, M. B. O mary, 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments, Curr. Opin. Cell Biol., 14 (2002), 110-122.
    [32] R. Moll, M. Divo, L. Langbein, The human keratins: biology and pathology, Histochem. Cell Biol., 129 (2008), 705-733. doi: 10.1007/s00418-008-0435-6. doi: 10.1007/s00418-008-0435-6
    [33] J. I. Epstein, An update of the Gleason grading system, J. Urol., 183 (2010), 433-440. doi: 10.1016/j.juro.2009.10.046. doi: 10.1016/j.juro.2009.10.046
    [34] S. Liu, R. M. Cadaneanu, B. Zhang, L. Huo, K. Lai, X. Li, et al., Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone, PLoS One, 11 (2016), e0163232. doi: 10.1371/journal.pone.0163232.
    [35] S. Bundela, A. Sharma, P. S. Bisen, Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70, PLoS One, 9 (2014), e102610. doi: 10.1371/journal.pone.0102610.
    [36] J. A. Sharp, S. L. Mailer, P. C. Thomson, C. Lefevre, K. R. Nicholas, Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line, Mol. Cancer, 7 (2008), 1. doi: 10.1186/1476-4598-7-1.
    [37] L. Lima, M. Neves, M. I. Oliveira, L. Dieguez, R. Freitas, R. Azevedo, et al., Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases, Urol. Oncol., 35 (2017), 675 e1-675 e8. doi: 10.1016/j.urolonc.2017.08.012.
    [38] M. Eckstein, R. M. Wirtz, M. Gross-Weege, J. Breyer, W. Otto, R. Stoehr, et al., mRNA-expression of KRT5 and KRT20 defines distinct prognostic subgroups of muscle-invasive urothelial bladder cancer correlating with histological variants, Int. J. Mol. Sci., 19 (2018). doi: 10.3390/ijms19113396.
    [39] S. W. Cho, J. Xu, R. Sun, M. R. Mumbach, A. C. Carter, Y. G. Chen, et al., Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element, Cell, 173 (2018), 1398-1412. doi: 10.1016/j.cell.2018.03.068.
    [40] Y. Wang, C. E. Kaiser, B. Frett, H. Y. Li, Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators, J. Med. Chem., 56 (2013), 5219-5230. doi: 10.1021/jm3017706. doi: 10.1021/jm3017706
    [41] S. A. Kerk, T. Papagiannakopoulos, Y. M. Shah, C. A. Lyssiotis, Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment, Nat. Rev. Cancer, 21 (2021), 510-525. doi: 10.1038/s41568-021-00375-9. doi: 10.1038/s41568-021-00375-9
    [42] J. Huang, Current developments of targeting the p53 signaling pathway for cancer treatment, Pharmacol. Ther., 220 (2021), 107720. doi: 10.1016/j.pharmthera.2020.107720.
    [43] A. Kamoun, A. de Reynies, Y. Allory, G. Sjodahl, A. G. Robertson, R. Seiler, et al., A consensus molecular classification of muscle-invasive bladder cancer, Eur. Urol., 77 (2020), 420-433. doi: 10.1016/j.eururo.2019.09.006.
    [44] M. Fraga, M. Yanez, M. Sherman, F. Llerena, M. Hernandez, G. Nourdin, et al., Immunomodulation of t helper cells by tumor microenvironment in oral cancer is associated with ccr8 expression and rapid membrane vitamin d signaling pathway, Front. Immunol., 12 (2021), 643298. doi: 10.3389/fimmu.2021.643298.
    [45] K. D. da Silva, P. C. Caldeira, A. M. Alves, A. C. U. Vasconcelos, A. P. N. Gomes, M. C. F. de Aguiar, et al., High CD3(+) lymphocytes, low CD66b(+) neutrophils, and scarce tumor budding in the invasive front of lip squamous cell carcinomas, Arch. Oral. Biol., 104 (2019), 46-51. doi: 10.1016/j.archoralbio.2019.05.027.
    [46] O. Stasikowska-Kanicka, M. Wagrowska-Danilewicz, M. Danilewicz, Immunohistochemical analysis of foxp3(+), CD4(+), CD8(+) cell infiltrates and PD-L1 in oral squamous cell carcinoma, Pathol. Oncol. Res., 24 (2018), 497-505. doi: 10.1007/s12253-017-0270-y.
    [47] Y. Wei, B. Han, W. Dai, S. Guo, C. Zhang, L. Zhao, et al., Exposure to ozone impacted Th1/Th2 imbalance of CD(4+) T cells and apoptosis of ASMCs underlying asthmatic progression by activating lncRNA PVT1-miR-15a-5p/miR-29c-3p signaling, Aging (Albany NY), 12 (2020), 25229-25255. doi: 10.18632/aging.104124.
    [48] O. Demaria, E. Vivier, Immuno-oncology beyond TILs: Unleashing TILCs, Cancer Cell, 37 (2020), 428-430. doi: 10.1016/j.ccell.2020.03.021. doi: 10.1016/j.ccell.2020.03.021
    [49] J. Fu, H. Shi, B. Wang, T. Zhan, Y. Shao, L. Ye, et al., LncRNA PVT1 links Myc to glycolytic metabolism upon CD4(+) T cell activation and Sjogren's syndrome-like autoimmune response, J. Autoimmun., 107 (2020), 102358. doi: 10.1016/j.jaut.2019.102358.
    [50] J. Vivian, A. A. Rao, F. A. Nothaft, C. Ketchum, J. Armstrong, A. Novak, et al., Toil enables reproducible, open source, big biomedical data analyses, Nat. Biotechnol., 35 (2017), 314-316. doi: 10.1038/nbt.3772.
    [51] S. Hanzelmann, R. Castelo, J. Guinney, GSVA: gene set variation analysis for microarray and RNA-seq data, BMC Bioinformatics, 14 (2013), 7. doi: 10.1186/1471-2105-14-7.
    [52] G. Bindea, B. Mlecnik, M. Tosolini, A. Kirilovsky, M. Waldner, A. C. Obenauf, et al., Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, Immunity, 39 (2013), 782-795. doi: 10.1016/j.immuni.2013.10.003.
    [53] J. Liu, T. Lichtenberg, K. A. Hoadley, L. M. Poisson, A. J. Lazar, A. D. Cherniack, et al., An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics, Cell, 173 (2018), 400-416. doi: 10.1016/j.cell.2018.02.052.
  • This article has been cited by:

    1. Prasanga Madhushani Kumarage, Liyana Arachchilage Dinithi Sandunika De Silva, Gang-Joon Heo, Aquatic environments: A potential source of antimicrobial-resistant Vibrio spp., 2022, 133, 1365-2672, 2267, 10.1111/jam.15702
    2. Raquiba Sultana, Al Mahmud, Sayad Mahmud Koli, Jannatul Nayema, Aboni Ghosh, Susmita Banik Sushree, Pranta Shom, Tanvir Ahmed Siddiqui, Kamal Kanta Das, Mrityunjoy Acharjee, Isolation and Identification of Vibrio Species from Different Types of Water Sources Along with Their Drug Susceptible Pattern, 2024, 8, 2588-9834, 207, 10.4103/bbrj.bbrj_138_24
    3. Aaron Awere‐Duodu, Onyansaniba K. Ntim, Eric S. Donkor, Vibrio cholerae in Water Environments: A Systematic Review and Meta‐Analysis, 2025, 17, 1758-2229, 10.1111/1758-2229.70103
    4. Bright E IGERE, ONOHUEAN Hope, P.O Adomi, T Bashiru Abeni, Phenicol antibiotic resistance status amongst environmental non-O1/non-O139 Vibrio cholerae and Clinical O1/O139 Vibrio cholerae strains: a systematic review and meta-synthesis, 2025, 29501946, 100474, 10.1016/j.microb.2025.100474
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3825) PDF downloads(168) Cited by(1)

Figures and Tables

Figures(7)  /  Tables(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog